<DOC>
	<DOC>NCT02191215</DOC>
	<brief_summary>The aim of the Post Marketing Study (PMS) is to evaluate the efficacy and safety profile of nevirapine in the management of the HIV/AIDS in an open environment.</brief_summary>
	<brief_title>Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>diagnosis of HIV/AIDS, no age limits patients could be na√Øve to treatment or pretreated with other antiretroviral agents Patients with known hypersensitivity to nevirapine or any other component of the product</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>